{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:54:42Z","timestamp":1777046082749,"version":"3.51.4"},"reference-count":34,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Hypocalcemia predisposes patients with chronic hypoparathyroidism (cHypoPT) to an increased risk of QTc prolongation and life-threatening arrhythmias. Information on clinical and biochemical correlates of QTc in cHypoPT is limited.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To assess the significance of QTc interval in chronic hypoparathyroidism and its correlates.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was an observational cohort study at a tertiary care center. Eighty-eight nonsurgical patients with cHypoPT (mean age 44.1 \u00b1 15.4 years, 45 males) were assessed for QTc interval and its possible correlates including arrhythmic symptoms (palpitation\/giddiness\/syncope), serum total calcium, phosphate, 25(OH)D, and intact parathyroid hormone.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The mean QTc in the HypoPT cohort was 428 \u00b1 34\u2005ms with 13.6% having prolonged QTc. There was a significant inverse correlation between QTc interval and serum total calcium measured on the same day (r = \u22120.43, P &amp;lt; .001). The mean serum total calcium was significantly lower in patients with prolonged QTc (7.05 \u00b1 1.94 vs 8.49 \u00b1 1.01\u2005mg\/dL, P = .02). Of patients with cHypoPT 21.6% had arrhythmic symptoms. They had significantly higher mean QTc (P = .02) and also tended to have lower mean serum total calcium during follow-up (P = .06). In multivariable regression, female gender, higher current age, higher body mass index, and low serum total calcium showed significant association with prolonged QTc. For every mg\/dL decrease in serum total calcium, QTc increased by 13\u2005ms. Receiver operating characteristic analysis revealed serum total calcium at cut-off of 8.3\u2005mg\/dL discriminated prolonged QTc with area under the curve being 0.72 (95% CI 0.51, 0.93).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>One-fifth of patients with cHypoPT had arrhythmic symptoms and a significant proportion had prolonged QTc. This highlights the need for close monitoring of patients with cHypoPT for arrhythmic symptoms and QTc prolongation. The serum total calcium should be maintained to at least 8.3\u2005mg\/dL to minimize the risk of potentially life-threatening arrhythmia in cHypoPT.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae346","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T18:26:11Z","timestamp":1715970371000},"page":"e1062-e1067","source":"Crossref","is-referenced-by-count":5,"title":["Significance of QTc Interval in Chronic Hypoparathyroidism and its Correlates"],"prefix":"10.1210","volume":"110","author":[{"given":"Preeti","family":"Namjoshi","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, All India Institute of Medical Sciences , New Delhi 110029 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soma","family":"Saha","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, All India Institute of Medical Sciences , New Delhi 110029 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibhav","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, All India Institute of Medical Sciences , New Delhi 110029 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mani","family":"Kalaivani","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, All India Institute of Medical Sciences , New Delhi 110029 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9634-5887","authenticated-orcid":false,"given":"Rajiv","family":"Narang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, All India Institute of Medical Sciences , New Delhi 110029 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3097-5074","authenticated-orcid":false,"given":"Ravinder","family":"Goswami","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, All India Institute of Medical Sciences , New Delhi 110029 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2024,5,17]]},"reference":[{"issue":"12","key":"2025031717045162000_dgae346-B1","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1002\/jbmr.4691","article-title":"Evaluation and management of hypoparathyroidism summary statement and guidelines from the second international workshop","volume":"37","author":"Khan","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2025031717045162000_dgae346-B2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2265.2012.04353.x","article-title":"Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism","volume":"77","author":"Goswami","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2025031717045162000_dgae346-B3","doi-asserted-by":"crossref","first-page":"dgz319","DOI":"10.1210\/clinem\/dgz319","article-title":"Nephrocalcinosis, renal dysfunction, and calculi in patients with primary hypoparathyroidism on long-term conventional therapy","volume":"105","author":"Saha","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2025031717045162000_dgae346-B4","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1002\/jbmr.4673","article-title":"Complications, symptoms, presurgical predictors in patients with chronic hypoparathyroidism: a systematic review","volume":"37","author":"Yao","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2025031717045162000_dgae346-B5","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/jbmr.2501","article-title":"The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study","volume":"30","author":"Underbjerg","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2025031717045162000_dgae346-B6","doi-asserted-by":"crossref","first-page":"e0232842","DOI":"10.1371\/journal.pone.0232842","article-title":"Prevalence and complications of nonsurgical hypoparathyroidism in Korea: a nationwide cohort study","volume":"15","author":"Kim","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"2025031717045162000_dgae346-B7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/cen.13895","article-title":"Increased mortality and morbidity in patients with chronic hypoparathyroidism: a population-based study","volume":"90","author":"Vadiveloo","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"24","key":"2025031717045162000_dgae346-B8","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1161\/CIRCULATIONAHA.119.039598","article-title":"The QT interval","volume":"139","author":"Giudicessi","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"2025031717045162000_dgae346-B9","first-page":"56","article-title":"The electrocardiogram in hypocalcemia with special reference to T-wave","volume":"136","author":"O","year":"1949","journal-title":"Acta Med Scand"},{"issue":"6","key":"2025031717045162000_dgae346-B10","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1210\/jc.2010-2969","article-title":"Serum 25-hydroxyvitamin D, calcium, phosphorus, and electrocardiographic QT interval duration: findings from NHANES III and ARIC","volume":"96","author":"Zhang","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025031717045162000_dgae346-B11","doi-asserted-by":"crossref","first-page":"e12496","DOI":"10.1111\/anec.12496","article-title":"Parathyroid hormone is related to QT interval independent of serum calcium in patients with coronary artery disease","volume":"23","author":"Palmeri","year":"2018","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"7","key":"2025031717045162000_dgae346-B12","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1210\/clinem\/dgab162","article-title":"Basal ganglia calcification is associated with local and systemic metabolic mechanisms in adult hypoparathyroidism","volume":"106","author":"Zavatta","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025031717045162000_dgae346-B13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00774-016-0767-6","article-title":"Long-term outcome of cataract surgery in patients with idiopathic hypoparathyroidism and its relationship with their calcemic status","volume":"35","author":"Saha","year":"2017","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"2025031717045162000_dgae346-B14","first-page":"251","article-title":"Vertebral fractures and bone mineral density in patients with idiopathic hypoparathyroidism on long-term follow-up","volume":"102","author":"Chawla","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025031717045162000_dgae346-B15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1530\/EJE-12-0946","article-title":"Neuropsychological dysfunction in idiopathic hypoparathyroidism and its relationship with intracranial calcification and serum total calcium","volume":"168","author":"Aggarwal","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2025031717045162000_dgae346-B16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/eje.0.1500009","article-title":"Prevalence of calcium sensing receptor autoantibodies in patients with sporadic idiopathic hypoparathyroidism","volume":"150","author":"Goswami","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2025031717045162000_dgae346-B17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1530\/EJE-09-0303","article-title":"Presence and significance of a R110W mutation in the DNA-binding domain of GCM2 gene in patients with isolated hypoparathyroidism and their family members","volume":"162","author":"Tomar","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2025031717045162000_dgae346-B18","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1210\/jc.2018-02228","article-title":"Auditing the efficacy and safety of alfacalcidol and calcium therapy in idiopathic hypoparathyroidism","volume":"104","author":"Saha","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025031717045162000_dgae346-B19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/cen.14872","article-title":"Coronary artery disease and its vascular associates in patients with chronic nonsurgical hypoparathyroidism","volume":"98","author":"Saha","year":"2023","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"2025031717045162000_dgae346-B20","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1002\/jbmr.4667","article-title":"Hypoparathyroidism: genetics and diagnosis","volume":"37","author":"Mannstadt","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2025031717045162000_dgae346-B21","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1002\/jbmr.4714","article-title":"Etiology and pathophysiology of hypoparathyroidism: a narrative review","volume":"37","author":"Pasieka","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2025031717045162000_dgae346-B22","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1210\/jc.2013-2158","article-title":"Calcium-sensing receptor autoantibodies and idiopathic hypoparathyroidism","volume":"98","author":"Tomar","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025031717045162000_dgae346-B23","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/cen.12850","article-title":"Prevalence of coeliac disease in idiopathic hypoparathyroidism and effect of gluten-free diet on calcaemic control","volume":"84","author":"Saha","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025031717045162000_dgae346-B24","first-page":"353","article-title":"An analysis of the time-relations of the electrocardiogram","volume":"7","author":"Bazett","year":"1918","journal-title":"Heart"},{"key":"2025031717045162000_dgae346-B25","first-page":"1922","article-title":"QT interval in human electrocardiogram in absence of cardiac disease","volume":"78","author":"Carter","year":"1922","journal-title":"JAMA"},{"issue":"6","key":"2025031717045162000_dgae346-B26","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1210\/jc.2015-3907","article-title":"Management of hypoparathyroidism: summary statement and guidelines","volume":"101","author":"Brandi","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025031717045162000_dgae346-B27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tcm.2017.07.012","article-title":"Effect of age and gender on the QTc-interval in healthy individuals and patients with long-QT syndrome","volume":"28","author":"Vink","year":"2018","journal-title":"Trends Cardiovasc Med"},{"issue":"4","key":"2025031717045162000_dgae346-B28","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.orcp.2016.09.005","article-title":"Association of corrected QT interval with body mass index, and the impact of this association on mortality: results from the third national health and nutrition examination survey","volume":"11","author":"Waheed","year":"2017","journal-title":"Obes Res Clin Pract"},{"issue":"11","key":"2025031717045162000_dgae346-B29","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1210\/jc.2019-01010","article-title":"Safety and efficacy of 5 years of treatment with recombinant human parathyroid hormone in adults with hypoparathyroidism","volume":"104","author":"Mannstadt","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025031717045162000_dgae346-B30","doi-asserted-by":"crossref","first-page":"bvad043","DOI":"10.1210\/jendso\/bvad043","article-title":"Long-term safety and efficacy of recombinant human parathyroid hormone (1-84) in adults with chronic hypoparathyroidism","volume":"7","author":"Watts","year":"2023","journal-title":"J Endocr Soc"},{"issue":"1","key":"2025031717045162000_dgae346-B31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jbmr.4726","article-title":"Efficacy and safety of parathyroid hormone replacement with TransCon PTH in hypoparathyroidism: 26-week results from the phase 3 PaTHway trial","volume":"38","author":"Khan","year":"2023","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2025031717045162000_dgae346-B32","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00246-019-02151-x","article-title":"Long QT syndrome: genetics and future perspective","volume":"40","author":"Wallace","year":"2019","journal-title":"Pediatr Cardiol"},{"issue":"8","key":"2025031717045162000_dgae346-B33","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1007\/s12325-021-01787-7","article-title":"Risk of cardiovascular conditions in patients with chronic hypoparathyroidism: a retrospective cohort study","volume":"38","author":"Gosmanova","year":"2021","journal-title":"Adv Ther"},{"issue":"1149","key":"2025031717045162000_dgae346-B34","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/postgradmedj-2020-138661","article-title":"Managing drug-induced QT prolongation in clinical practice","volume":"97","author":"Khatib","year":"2021","journal-title":"Postgrad Med J"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae346\/58198788\/dgae346.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/4\/e1062\/58198788\/dgae346.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/4\/e1062\/58198788\/dgae346.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T17:05:17Z","timestamp":1742231117000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/4\/e1062\/7676108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,17]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,5,17]]},"published-print":{"date-parts":[[2025,3,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae346","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,5,17]]}}}